Back to Search
Start Over
β1-selective adrenoceptor antagonists increase plasma levels of anti-p2β antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease.
- Source :
-
The Canadian journal of cardiology [Can J Cardiol] 2014 Mar; Vol. 30 (3), pp. 332-7. Date of Electronic Publication: 2013 Dec 25. - Publication Year :
- 2014
-
Abstract
- Background: Studies indicate that antibodies cross-reacting with cardiac β1 adrenergic receptors are likely to play a role in the development of chronic Chagas heart disease (CCHD). In parallel, clinical trials have shown that β1 antagonist drugs exert beneficial effects in the prognosis of patients with CCHD. In a group of patients with CCHD undergoing therapy with β1-blockers, we have now evaluated the levels of anti-p2β antibodies and the severity of CCHD.<br />Methods: We performed a cross-sectional study in Trypanosoma cruzi seropositive patients categorized according to a standard CCHD classification. All individuals were subjected to a complete clinical examination.<br />Results: There was no association between CCHD stages, electrocardiographic conduction disturbances, and echocardiogram pathological signs with the levels of autoantibodies. However, when patients were analyzed according to selective cardio-β1-blocker therapy, those receiving treatment had higher levels of anti-p2β. Patients from CCHD stage III treated with combined therapy of cardio-β1-selective blockers, enalapril, and statins, presented decreased cardiac involvement and lower score of risk of mortality than individuals from the same group who were not treated.<br />Conclusions: Our results suggest that selective cardio-β1-blockers might modify the autoantibody anti-p2β levels, and that combined therapy in patients with stage III CCHD might be associated with lower cardiac involvement and risk score of mortality in patients with heart failure. Longitudinal studies will help to ascertain the proper role of β1-blockers in the immunopathological processes underlying chronic Chagas disease.<br /> (Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)
- Subjects :
- Adult
Animals
Antibodies, Protozoan blood
Biomarkers blood
Chagas Cardiomyopathy immunology
Chronic Disease
Cross-Sectional Studies
Disease Progression
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Humans
Male
Middle Aged
Adrenergic beta-1 Receptor Antagonists blood
Antibodies, Protozoan immunology
Chagas Cardiomyopathy blood
Trypanosoma cruzi immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1916-7075
- Volume :
- 30
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The Canadian journal of cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 24370375
- Full Text :
- https://doi.org/10.1016/j.cjca.2013.09.017